Mirion Technologies, Inc. (MIR) AI Stock Analysis

Mirion Technologies, Inc. provides advanced radiation detection, measurement, analysis, and monitoring products and services globally. It serves medical and industrial sectors across countries including the United States, Canada, the UK, France, Germany, Finland, China, and Japan. The company operates through two primary segments: Medical and Industrial. The Medical segment provides radiation oncology quality assurance, dosimetry, patient safety solutions, radionuclide therapy products, shielding, and rehabilitation equipment. The Industrial segment delivers radiation safety and analysis applications, including personal radiation detection devices, contamination monitors, reactor instrumentation, control equipment, and alpha and gamma spectroscopy detector systems.

Mirion's revenue expanded at a 5-year CAGR of 14.1% between FY2020 and FY2025. Annual revenue rose from $611.6M in FY2021 to $717.8M in FY2022, $800.9M in FY2023, $860.8M in FY2024, and $925.4M in FY2025. Gross margin improved from 41.2% in FY2021 to 47.4% in FY2025. Following net income of -$158.3M in FY2021 and -$276.9M in FY2022, the company reached positive net income of $28.8M in FY2025 with an operating margin of 5.6%. In the trailing twelve months ended June 30, 2026, revenue totaled $1.02B, with quarterly revenue growth of 19.7% year-over-year and an operating margin of 7.2%.

As of June 30, 2026, Mirion held $425.3M in cash and short-term investments against total debt of $1.23B, resulting in net debt of $807.9M. The company maintains a current ratio of 3.20 and a debt-to-equity ratio of 0.68 on $1.83B in shareholders' equity. Operating cash flow improved to $143.3M in FY2025, driving free cash flow of $106.9M. During FY2025, capital expenditures were $36.4M, and share buybacks totaled $49.6M.

At its last close of $15.15 on October 16, 2026, Mirion had a market capitalization of $3.77B and an enterprise value of $4.89B. The stock trades at a trailing price-to-earnings ratio of 168.3x, compared to the 24.8x median of its US-listed Industrials peers. Its price-to-sales ratio of 3.7x and EV/EBITDA of 22.7x also sit above peer medians of 1.5x and 13.9x, respectively. Mirion shares fell 38.0% over the past year, trailing the S&P 500 (SPY) return of 16.8%.

Wall Street analysts hold 8 Strong Buy, 2 Buy, and 1 Hold ratings on Mirion, with zero Sell or Strong Sell ratings. The mean price target is $24.00, representing 58.4% upside against the last close of $15.15. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $1.14B and EPS of $0.55. Mirion surpassed EPS estimates in 3 of the last 4 quarters, with its next earnings date scheduled for October 27, 2026.

This page is an AI-written research summary of Mirion Technologies, Inc. (MIR). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: MIR income statement, MIR balance sheet, MIR key metrics, MIR analyst forecast, MIR chart. See the MIR stock overview for the latest quote and news.